PlainPharmaWatch

CMS Open Payments · Program Year 2024

Arteriocyte Medical Systems, Inc.

Arteriocyte Medical Systems, Inc. reported $300,150.39 in payments to 577 physicians and teaching hospitals across 577 transactions.

See the rankings → How this is sourced
$300.2K
Total payments
577
Transactions
577
Recipients
−$2.3M
General Payments vs PY2023

Arteriocyte Medical Systems, Inc. reported $300,150.39 in payments to 577 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #892 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $520.19 per recipient across 5 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Arteriocyte Medical Systems, Inc. pairs above-median payment volume with a broadly spread payment pattern across many recipients.

#892
of 1,925 companies
0.0%
of all US industry payments
0.2%
paid to its single top recipient
5
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Arteriocyte Medical Systems, Inc.'s CMS-reported General Payments decreased by $2.3M (−88.4%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: ARTERIOCYTE MEDICAL SYSTEMS, INC.PY2023: ARTERIOCYTE MEDICAL SYSTEMS, INC.PY2024: Arteriocyte Medical Systems, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$2.6MPY2024$300.2K
PY2023
$2,593,404.27
PY2024
$300,150.39

How Arteriocyte Medical Systems, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Arteriocyte Medical Systems, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$300,150 Top 46% higher than 54% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). This entry sits in this band. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Arteriocyte Medical Systems, Inc.

Averaging $520.19 per transaction and $520.19 per recipient, Arteriocyte Medical Systems, Inc.'s Program Year 2024 total comes to $300,150.39 across 577 transactions and 577 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #892 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

21 transactions worth $153.5K make "Consulting Fee" the top general-payment category in the 5-category breakdown below, 51.1% of the reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Consulting Fee" leads Arteriocyte Medical Systems, Inc.'s 5-category general-payment breakdown at $153.5K, 51.1% of the reported total.

How Arteriocyte Medical Systems, Inc. divides its payments

How the reported total splits across payment categories

1. Consulting Fee$153.5K2. Compensation for Services…$98.0K3. Food and Beverage$42.7K4. Grant$5.0K5. Travel and Lodging$1.0K
Payment Type Amount Transactions
Consulting Fee $153.5K 21
Compensation for Services Other Than Consulting $98.0K 27
Food and Beverage $42.7K 524
Grant $5.0K 1
Travel and Lodging $1.0K 4

Recipient Concentration in General Payments

The five largest recipient relationships account for $217,334.89 (72.4%) of $300,150.39 in this company's General Payments records across 344 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Arteriocyte Medical Systems, Inc.

The five named recipients with the highest reported General Payments from this company

Babajide Ogunseinde$65.4KPeter Passias$47.3KDarryl Lau$45.0KChristopher Silveri$40.2KKurt Hofmann$19.5K
  1. 1

    Babajide Ogunseinde

    $65,355.46 across 15 reported transactions

  2. 2

    Peter Passias

    $47,252.84 across 6 reported transactions

  3. 3

    Darryl Lau

    $45,000.00 across 3 reported transactions

  4. 4

    Christopher Silveri

    $40,226.59 across 5 reported transactions

  5. 5

    Kurt Hofmann

    $19,500.00 across 2 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $520.19. Average per recipient: $520.19.

Total Amount

$300,150.39

Avg per Transaction

$520.19

Avg per Recipient

$520.19

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Arteriocyte Medical Systems, Inc. Share

0.0%

#892 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Arteriocyte Medical Systems, Inc.

Episurf Medical, Inc.

$295.1K 34 recipients

Ottobock SE & Co. KGaA

$306.0K 4 recipients

Cryo Specialty Medical, LLC

$306.5K 35 recipients

IlluminOss Medical, Inc.

$293.7K 469 recipients

Verity Pharmaceuticals Inc.

$293.4K 4,640 recipients

Nexxt Spine LLC

$292.8K 358 recipients

Frequently Asked Questions

How much did Arteriocyte Medical Systems, Inc. pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $300,150.39 from Arteriocyte Medical Systems, Inc. to physicians and hospitals across 577 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Arteriocyte Medical Systems, Inc.? ▾
Averaging $520.19 per recipient, Arteriocyte Medical Systems, Inc.'s 2024 payments reached 577 physicians and teaching hospitals.
What types of payments did Arteriocyte Medical Systems, Inc. make? ▾
5 categories of general payment make up Arteriocyte Medical Systems, Inc.'s reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Consulting Fee" at $153.5K, representing 51.1% of the company's reported total.
How does Arteriocyte Medical Systems, Inc. rank among pharmaceutical companies? ▾
Arteriocyte Medical Systems, Inc. ranks #892 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from Arteriocyte Medical Systems, Inc.? ▾
In 2024, Arteriocyte Medical Systems, Inc. averaged $520.19 per transaction across 577 transactions to 577 recipients.
Where does the payment data for Arteriocyte Medical Systems, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Arteriocyte Medical Systems, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.